explore -WSS

explore

author：entertainment 2025-10-01 23:38:58 - browse：829

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Medicare drug price negotiation’s day in court

WSS

Vertigo drug brings hope for rare neuron disorder, Niemann

CDC Director Mandy Cohen on transparency, trust, and health

Do digital therapeutics have a future in medicine?

Why patients can’t get everything they want on drug pricing

Biden administration opens offers in Medicare drug price negotiations

Former reverend arrested for allegedly killing 8

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Biden warns of ‘dark winter’ during final presidental debate

In age of alternative facts, a scholarly course on calling out crap

Cybersecurity threat forces Lurie Children's to take systems offline

United colonoscopy coverage change 'may cost lives,' doctors say

Quicker fix for pulse oximeters urged during FDA public meeting

In Memoriam: Notable people who died in 2023

Roche’s Alnylam deal shows drug firms interested in heart drugs

BioMarin wins approval for gene therapy to treat hemophilia A

Some dementia cases could be undiagnosed liver disease

hotspot

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Senate panel puts off hardest PBM reforms for another day

Democrats decry new health bill for going easy on private equity

Will the FTC rein in IQVIA's health data empire?

Apple Vision Pro: A first look at health apps on the new VR headset

Democrats decry new health bill for going easy on private equity

hotspot

hotspot

knowledge

knowledge